(Q43918956)

28 November 2017

title

Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging (English)

1 reference

28 November 2017

I Ribizzi

1

1 reference

28 November 2017

J W Darnowski

2

1 reference

28 November 2017

F A Goulette

3

1 reference

28 November 2017

M S Akhtar

4

1 reference

28 November 2017

D Chatterjee

5

1 reference

28 November 2017

P Calabresi

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bone Marrow Transplantation

28 November 2017

published in

1 reference

28 November 2017

volume

29

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

313-319

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703359

28 November 2017

exact match

0 references

cites work

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

Immunologic purging of marrow assessed by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

7 January 2021

Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

7 January 2021

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

7 January 2021

NMR studies and GC analysis of the antibacterial agent taurolidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

7 January 2021

Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

7 January 2021

Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703359

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703359

1 reference

Dimensions Publication ID

28 November 2017

1040594814

0 references

1 reference